## COPADM #2 – Intermediate risk (Group B)

**Cyclophosphamide (CPM)**
-	Route: IV 
-	Dosage: 250 mg/m2/dose in 100ml NS to infuse over 1 hour twice a day
-   Dilute with 0.9% NaCl to a target concentration of < 20 mg/mL, administer via IV infusion over 1 hour
-	Used on Day 2 to 4 (total of 6 doses)
-	Caution: IV mesna 1000 mg/m2/dose in 250ml NS over 20 hours infusion at Day 2 to 4, to start with IV cyclophosphamide.

**VinCRIStine (O)**
-	Route: IV push over 1 minute
-	Dosage: 2 mg/m2/dose
-   Dilute with 10ml of 0.9% NaCl, IV infusion at 60ml/h
-	Used on Day 1
-	Caution: Maximum dose: 2 mg

**Prednisolone (P)**
-	Route: PO 
-	Dosage: 60 mg/m2/day in 2 divided doses
-	Used in days 1 to 5 
-	Caution: no tailing of dose

**Doxorubicin (A)**
-	Route: IV Push/infusion over 6h
-	Dosage: 60 mg/m²/dose
-   Dilute with 50ml of 0.9% NaCl, IV infusion at 50ml/h
-	Used on Day 2, after first dose of IV cyclophosphamide completely

**High Dose Methotrexate (DM)**
-	Route: IV over 4 hours
-	Dosage: 3 g/m2/dose, diluted in 250ml NS, infusion over 4 hours 
-	Used on Day 1
-	Caution: IV folinic 15 mg/m2/dose every 6 hourly x 4 doses starting at 24 hrs after start of IV MTX and continue until MTX level is < 0.1 uM.

**Triple Intrathecal (TIT)**

Triple intrathecal (IT) therapy doses, according to patient age, are as follows:
-	For patients under 1 year of age, administer methotrexate 8 mg, hydrocortisone 8 mg, and cytarabine 16 mg, in a total volume of 3 mL.
-	For patients aged 1 to 2 years, administer methotrexate 10 mg, hydrocortisone 10 mg, and cytarabine 20 mg, in a total volume of 4 mL.
-	For patients aged 2 to 3 years, administer methotrexate 12 mg, hydrocortisone 12 mg, and cytarabine 24 mg, in a total volume of 5 mL.
-	For patients older than 3 years, administer methotrexate 15 mg, hydrocortisone 15 mg, and cytarabine 30 mg, in a total volume of 6 mL.
-	These doses are to be given on Day 1 and Day 6

**G-CSF**
-	Route: subcutaneously
-	Dosage: 5 mcg/kg/day
-	Used on days 7 to 21. G-CSF should be discontinued when the post nadir ANC reaches 3000/mm3, even if prior to day 21. G-CSF should have been discontinued at least 48 hours prior the second COPAD course
